These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 20798236)
1. Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease. Bastien JP; Krosl G; Therien C; Rashkovan M; Scotto C; Cohen S; Allan DS; Hogge D; Egeler RM; Perreault C; Roy DC Blood; 2010 Dec; 116(23):4859-69. PubMed ID: 20798236 [TBL] [Abstract][Full Text] [Related]
2. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse. Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739 [TBL] [Abstract][Full Text] [Related]
3. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. Giorgini A; Noble A J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039 [TBL] [Abstract][Full Text] [Related]
4. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells. Ukena SN; Grosse J; Mischak-Weissinger E; Buchholz S; Stadler M; Ganser A; Franzke A Ann Hematol; 2011 Feb; 90(2):213-8. PubMed ID: 20859740 [TBL] [Abstract][Full Text] [Related]
6. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT. Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB Front Immunol; 2018; 9():3104. PubMed ID: 30733722 [TBL] [Abstract][Full Text] [Related]
7. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice. Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688 [TBL] [Abstract][Full Text] [Related]
8. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity. Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487 [TBL] [Abstract][Full Text] [Related]
9. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation. Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134 [TBL] [Abstract][Full Text] [Related]
10. The role of regulatory T cells in graft-versus-host disease management. Whangbo JS; Antin JH; Koreth J Expert Rev Hematol; 2020 Feb; 13(2):141-154. PubMed ID: 31874061 [No Abstract] [Full Text] [Related]
11. High frequency of CD4+ CD25- CD69+ T cells is correlated with a low risk of acute graft-versus-host disease in allotransplants. Lu SY; Huang XJ; Liu KY; Liu DH; Xu LP Clin Transplant; 2012; 26(2):E158-67. PubMed ID: 22507356 [TBL] [Abstract][Full Text] [Related]
12. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model. Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312 [TBL] [Abstract][Full Text] [Related]
13. A glucocorticoid amplifies IL-2-induced selective expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation. Xie Y; Wu M; Song R; Ma J; Shi Y; Qin W; Jin Y Acta Biochim Biophys Sin (Shanghai); 2009 Sep; 41(9):781-91. PubMed ID: 19727527 [TBL] [Abstract][Full Text] [Related]
14. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841 [TBL] [Abstract][Full Text] [Related]
15. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming. Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013 [TBL] [Abstract][Full Text] [Related]
16. TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment. Pierini A; Strober W; Moffett C; Baker J; Nishikii H; Alvarez M; Pan Y; Schneidawind D; Meyer E; Negrin RS Blood; 2016 Aug; 128(6):866-71. PubMed ID: 27365424 [TBL] [Abstract][Full Text] [Related]
18. Subpopulations of T Regulatory Cells in Blood Stem Cell Harvests Influence Development of Acute Graft Versus Host Disease in Allogeneic Transplant Recipients. Roschupkina T; Juliusson G Cytometry B Clin Cytom; 2018 Mar; 94(2):264-269. PubMed ID: 27479496 [TBL] [Abstract][Full Text] [Related]
19. A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique. Mielke S; Nunes R; Rezvani K; Fellowes VS; Venne A; Solomon SR; Fan Y; Gostick E; Price DA; Scotto C; Read EJ; Barrett AJ Blood; 2008 Apr; 111(8):4392-402. PubMed ID: 17878399 [TBL] [Abstract][Full Text] [Related]
20. Host CD25+CD4+Foxp3+ regulatory T cells primed by anti-CD137 mAbs inhibit graft-versus-host disease. Kim J; Kim W; Kim HJ; Park S; Kim HA; Jung D; Choi HJ; Park SJ; Mittler RS; Cho HR; Kwon B Biol Blood Marrow Transplant; 2012 Jan; 18(1):44-54. PubMed ID: 21958951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]